Mangoceuticals, Financial Statements From 2010 to 2025

MGRX Stock   3.64  0.27  6.91%   
Mangoceuticals, Common financial statements provide useful quarterly and yearly information to potential Mangoceuticals, Common Stock investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Mangoceuticals, Common financial statements helps investors assess Mangoceuticals, Common's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Mangoceuticals, Common's valuation are summarized below:
Mangoceuticals, Common Stock does not presently have any fundamental ratios for analysis.
Check Mangoceuticals, Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mangoceuticals, Common's main balance sheet or income statement drivers, such as , as well as many indicators such as . Mangoceuticals, financial statements analysis is a perfect complement when working with Mangoceuticals, Common Valuation or Volatility modules.
  
Check out the analysis of Mangoceuticals, Common Correlation against competitors.

Mangoceuticals, Common Stock Company Return On Asset Analysis

Mangoceuticals, Common's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Mangoceuticals, Common Return On Asset

    
  -0.62  
Most of Mangoceuticals, Common's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mangoceuticals, Common Stock is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Mangoceuticals, Common Stock has a Return On Asset of -0.6178. This is 92.94% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.

Mangoceuticals, Common Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Mangoceuticals, Common's current stock value. Our valuation model uses many indicators to compare Mangoceuticals, Common value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mangoceuticals, Common competition to find correlations between indicators driving Mangoceuticals, Common's intrinsic value. More Info.
Mangoceuticals, Common Stock is regarded third in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mangoceuticals, Common's earnings, one of the primary drivers of an investment's value.

About Mangoceuticals, Common Financial Statements

Mangoceuticals, Common investors use historical fundamental indicators, such as Mangoceuticals, Common's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mangoceuticals, Common. Please read more on our technical analysis and fundamental analysis pages.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Mangoceuticals, Stock Analysis

When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.